Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

γδ T cells adapt uniquely to different tissues in mice.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

MC-1R in skin cells may influence inflammation and collagen production.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Blocking a specific immune cell signal can trigger hair growth.

Atopy and altered T cell functions contribute to Alopecia Areata.

Canakinumab's effect on COVID-19 outcomes is unclear.

Certain inflammatory factors may increase or decrease the risk of developing PCOS.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

IL-18 signaling helps mature Tregs move into the thymus.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

LONRF1 is important for oxidative damage response and tissue remodeling during wound healing.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Overexpressing PKCα in mice skin increases inflammation but doesn't affect tumor growth.

Stem cell vesicles reduced eczema symptoms in mice safely.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Four specific genes are linked to keloid formation and could be potential treatment targets.